Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Evans Terry L received 168 Fennec Pharmaceuticals Inc. shares as an award (Form 4)

Traded Jun 30, 2026 · Filed Jul 1, 2026

On Jun 30, 2026, Evans Terry L (Chief Commercial Officer) received 168 Fennec Pharmaceuticals Inc. shares as an award, leaving 21,183 shares. Filed Jul 1, 2026 (Form 4).

Awarded
168 shares
Holding after
21,183 shares
Trading plan
No
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 30, 2026Common SharesAward16821,183Direct

Source

View original at SEC

Related